siRNA treatment targeting integrin α11 overexpressed via EZH2- driven axis inhibits drug-resistant breast cancer progression
Preprint in Research Square (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Preprint in Research Square (February 2024)
Article in Breast Cancer Research (January 2024)
Article in iScience (September 2023)